Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation.
about
Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantationAdoptive T cell therapy for cancer in the clinicTowards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapyChimeric Antigen Receptors Modified T-Cells for Cancer TherapyAdoptive T-cell therapy for cancer: The era of engineered T cellsClinical imaging in regenerative medicineCurrent translational and clinical practices in hematopoietic cell and gene therapyAntiviral T-cell therapyIn vivo imaging of therapy-induced anti-cancer immune responses in humans.Engineering human T cells for resistance to methotrexate and mycophenolate mofetil as an in vivo cell selection strategyPotent Sensitisation of Cancer Cells to Anticancer Drugs by a Quadruple Mutant of the Human Deoxycytidine KinaseIn vivo imaging of T cell delivery to tumors after adoptive transfer therapy.Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors.Allogeneic lymphocytes persist and traffic in feral MHC-matched mauritian cynomolgus macaquesEfficient selection of genetically modified human T cells using methotrexate-resistant human dihydrofolate reductase.Strategies to genetically engineer T cells for cancer immunotherapy.Chimeric receptor mRNA transfection as a tool to generate antineoplastic lymphocytesAn Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells.Development of an inducible caspase-9 safety switch for pluripotent stem cell-based therapiesA Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy.Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.HSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized mice.Suicide genes: monitoring cells in patients with a safety switch.Improving the safety of cell therapy with the TK-suicide geneAdoptive T-cell therapy: adverse events and safety switches.Clinical application of genetically modified T cells in cancer therapy.A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells.Regulated apoptosis of genetically modified hematopoietic stem and progenitor cells via an inducible caspase-9 suicide gene in rhesus macaques.Targeting of herpes simplex virus 1 thymidine kinase gene sequences into the OCT4 locus of human induced pluripotent stem cells.A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cellsChimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacyCell tracking in cardiac repair: what to image and how to image.NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic maStructure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe.Genetic control of wayward pluripotent stem cells and their progeny after transplantation.Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging.Improving TCR Gene Therapy for Treatment of Haematological Malignancies.Cell fate control gene therapy based on engineered variants of human deoxycytidine kinaseAntitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans.
P2860
Q24642254-B5327ECA-961D-4D82-8E7F-42FF8831FEBCQ24680405-FBD8FE4B-1AD4-48AC-8DD1-85332966D7F1Q26771159-FD9D5A4B-69CD-4EFE-ABE2-4EFBEEEF9D36Q26773309-A936E9E4-4388-460F-8DA3-F3E971A75203Q26800611-CA5B0CE3-18DD-46E6-A751-C9A2A8F1BB8BQ26851906-8D4680B3-E7CA-4D11-AA63-69A94EEF9600Q27024456-96C43995-34E8-4FFF-89D4-8C8BD59673A3Q27028006-A5917451-0C47-4A4D-8CE6-A57A68ECFF61Q27693338-0694074B-4EE8-48D6-943B-3FB0BECA6243Q28533690-DF09C0EE-5BD6-484D-B14B-5B871F04328BQ28550404-41E96876-F450-4746-9BFB-768E8C6FB707Q30479855-2C9C0B4D-575A-4E9E-A4D4-C159AB41C3F0Q30828860-224AC8B4-9435-4B3C-8B41-4223B7613765Q33342850-56C88D10-D8C1-40CF-8C2C-8C7755C6B650Q33637665-F8B4304C-61BB-4075-B8C3-BDC145737700Q33655849-768BDB89-77E7-4D4D-A8B8-DBE713146E79Q33791998-84861B0B-1498-4856-9382-3C22DAC3014AQ34044130-DA7DAC53-6BF6-44B8-A867-C7FAEE41482DQ34044181-27057C96-FAA3-43EA-962F-C730FDC10309Q34044757-0AE63FE8-F4A8-41B4-8400-B1755A542008Q34122292-F951DDB9-9CB0-411B-909C-CFAC6EE1B588Q34163218-462DB29F-5C28-4EDD-95B9-42A33CBC542AQ34204696-BAA2C59B-6D3A-4C5F-914A-8075FE45E1CFQ34462056-1DBF89B7-8BAD-4D7B-B7A0-51F27AA27ED8Q34477411-CFFF38A8-63CD-4108-9F15-E9FF73E5E859Q34511623-04112767-E33F-4BCD-A9B6-11066519DF8BQ34511646-DA221E5B-5857-4F42-924C-D5BEF375E58BQ34625160-3E55BE77-93B3-47C5-946C-FF7A1841E1BFQ34734779-EF8F15C3-4FA6-46D9-97FD-B457C973E62CQ35060433-FC65E6DF-583E-4897-B0D4-5270AAC4DB02Q35153765-F989AF14-FDFA-4739-9913-6205FBC99302Q35399080-93E40257-12FB-47E1-89D7-4D75BBCEA2B3Q35589728-FE7A112A-C8FA-4CFF-9E51-D2308AEAEBA5Q35605318-4CAB52C7-AAE6-45C7-970D-0D1ACCF279EBQ35643725-990357F2-4504-4A12-A509-F6BAD3E9216BQ35661899-52D24203-B4C4-4B2A-B195-7EF140061F15Q35719906-A52B4571-F84D-4EE0-9806-6597E0E2232FQ35738738-A7CBD539-34CD-4FE1-8931-0AC320247FACQ35939470-4E954314-A1C0-4340-A4A5-5FEC3B2742AAQ36060239-B33D0B0B-284F-4E89-91C2-C440FFC8B428
P2860
Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Analysis of transgene-specific ...... opoietic cell transplantation.
@ast
Analysis of transgene-specific ...... opoietic cell transplantation.
@en
type
label
Analysis of transgene-specific ...... opoietic cell transplantation.
@ast
Analysis of transgene-specific ...... opoietic cell transplantation.
@en
prefLabel
Analysis of transgene-specific ...... opoietic cell transplantation.
@ast
Analysis of transgene-specific ...... opoietic cell transplantation.
@en
P2093
P2860
P1433
P1476
Analysis of transgene-specific ...... opoietic cell transplantation.
@en
P2093
Carolina Berger
Edus H Warren
Mary E Flowers
Stanley R Riddell
P2860
P304
P356
10.1182/BLOOD-2005-08-3503
P407
P577
2005-11-10T00:00:00Z